We specialize in the advanced botanical extraction and mass bulk supply of 98% Baicalein, a high-purity natural flavonoid monomer refined from premium dried scutellaria root (Scutellaria baicalensis). Through sophisticated multi-stage water extraction, macroporous resin separation, and low-temperature recrystallization purification technology, we produce uniform orange-yellow needle-like crystals.

The entire production workflow utilizes a pure physical purification process within our 100,000-class GMP dust-free closed workshops, ensuring full batch quality traceability. Every single batch is strictly calibrated via High-Performance Liquid Chromatography (HPLC) to guarantee a stable 98% monomer purity. We supply stable, low-impurity compliant raw materials for global cosmetic factories, health supplement brands, and biomedical research institutions.

• Light Sensitivity Storage: Baicalein crystal is highly sensitive to strong light. Long-term light exposure will cause discoloration and active degradation; it must be fully sealed and stored in a dark environment.

• Solubility Matching: Slightly soluble in water, but easily soluble in ethanol, propylene glycol, and glycerin. Aqueous formulations require appropriate polyol cosolvents to prevent precipitation.

• Production Operation Protection: Personnel must wear dust-proof masks and gloves during weighing and feeding to prevent respiratory and skin contact irritation from the fine crystal powder.

• Formula pH Adaptation: The optimal formula pH range is 4.5–7.5. A strong alkaline environment will destroy the flavonoid structure and severely reduce its biological efficacy.

• Compatibility Reminder: Avoid simultaneous matching with high-concentration oxidants in a formula, as this will prematurely consume the antioxidant activity of Baicalein.

• Transportation Protection: Packaging must be strictly moisture-proof and light-proof. Prevent extrusion or impact damage that could lead to crystal leakage and compromised seal integrity.

• Target Crowd Reference: Oral formulas intended for pregnant women and infants require thorough safety stability testing prior to mass commercial production.